Sponsored Content
Pfizer Invests 50 Million Euros in Lower Austria
Pfizer is expanding its site in Orth an der Donau by investing 50 million euros in the construction of new laboratories for an international quality control center for vaccines, the construction of modern office space and the modernization and expansion of the existing production infrastructure. Pfizer already produces two vaccines for worldwide export in Orth an der Donau.
Symbolic ground-breaking ceremony. (left to right) Prof. Dr. Robin Rumler (MD Pfizer Austria), Nanette Cocero (Vaccines Pfizer Inc.), Martin Dallinger (MD), Albert Bourla (CEO Pfizer Inc.), Michaela Eder (Head of EHS), Bernd Rinne, Hannes Dengg. / Picture: © Pfizer Austria
With a symbolic ground-breaking ceremony, the pharmaceutical company Pfizer has given the go-ahead for a comprehensive expansion of its production facility in Orth an der Donau (Lower Austria).
A total of 50 million euros will be invested in the construction of new laboratories for an international quality control centre for vaccines, the construction of modern office space and…
or Log In
Fast News Search